Skip to main content
Equibles

MORGAN STANLEY

Position in BRNS — Barinthus Biotherapeutics plc.

CIK 895421 NEW YORK, NY
Back to BRNS Full portfolio

Position in BRNS

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$71,835
+$70,579 QoQ
Shares Held
108,843
+4825.0% QoQ
Ownership
0.266%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#7
of 15 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in BRNS Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

MORGAN STANLEY holds $16,838,649,954 across 523 Biotechnology names. BRNS ranks #362 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 RPRX
Royalty Pharma plc
 42,931,597 $2,407,174,637
2 VRTX
Vertex Pharmaceuticals Inc / Ma
 3,242,139 $1,610,467,694
3 ROIV
Roivant Sciences Ltd.
 42,592,905 $1,507,362,901
4 REGN
Regeneron Pharmaceuticals, Inc.
 1,397,712 $871,529,332
5 MRNA
Moderna, Inc.
 9,538,094 $667,952,718
6 ARGX
Argenx SE
 643,123 $596,670,219
7 TECH
BIO-TECHNE Corp
 6,374,717 $450,373,747
8 INCY
Incyte Corp
 2,948,364 $334,226,536

All Filings in BRNS

Export CSV
21 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $71,835 108,843
2026-03-31 $1,256 2,210
2025-12-31 $2,383 3,406
2025-09-30 $6,177 4,942
2025-06-30 $4,511 4,852
2025-03-31 $847 871
2024-12-31 $9,689 8,021
2024-09-30 $14,259 11,983
2024-06-30 $12,422 8,873
2024-03-31 $30,611 12,862
2023-12-31 $60,763 16,467
2023-09-30 $65,554 21,215
2023-06-30 $31,820 15,447
2023-03-31 $154,104 68,797
2022-12-31 $27,764 11,815
2022-09-30 $40,217 12,568
2022-06-30 $61,449 13,809
2022-03-31 $48,349 9,298
2021-12-31 $106,999 9,631
2021-09-30 $378,923 24,074
2021-06-30 $283,263 16,881